z-logo
open-access-imgOpen Access
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation
Author(s) -
Rajesh T. Gandhi,
Deborah McMahon,
Ronald J. Bosch,
Christina M. Lalama,
Joshua C. Cyktor,
Bernard Macatangay,
Charles R. Rinaldo,
Sharon A. Riddler,
Evelyn Hogg,
Catherine Godfrey,
Ann C. Collier,
Joseph J. Eron,
John W. Mellors
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/89ey-rm15
Subject(s) - persistence (discontinuity) , antiretroviral therapy , inflammation , human immunodeficiency virus (hiv) , medicine , immunology , virology , viral load , geotechnical engineering , engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here